Skip to main content

Table 3 Mean cyst burden per mouse brain 30 days after injection with5 cysts of PRU strain by intragastrical route

From: Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice

Group (n = 5)

No. of brain cysts*

Reduction (%)#

CAV-2-ROP18 (I)

8000 ± 1414a

57.3

CAV-2 (II)

17480 ± 1584b

6.6

PBS (III)

18080 ± 642b

3.4

Blank Control (IV)

18720 ± 955b

-

  1. *Data are reported as mean ± SD.
  2. a,bThe same letter indicates no difference (P > 0.05), whereas different letters indicate a significant difference (P < 0.05).
  3. #From the values for the blank control.